what to expect the first week on semaglutide What to Expect During the
Description
Who Is Eligible Roughly 10% of Medicare enrollees (~3.4 million people) are expected to qualify for GLP-1 coverage

Post-marketing data have not revealed an increased incidence of MTC in patients treated with these medications, though the baseline incidence of this rare cancer type is very low (approximately 1-2 cases per 100,000 people annually)

Clinical trials establishing the efficacy of these medications, including the STEP trials for semaglutide and the SURMOUNT trials for tirzepatide, all paired pharmacotherapy with structured lifestyle interventions, such as dietary counseling and physical activity targets

The NAD(+)/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling